
399
recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC
study): a randomized trial. Lancet 2002;359:2053-8.
703. Lederman RJ, Mendelsohn FO, Santos R, et al. Primary renal artery stenting:
characteristics and outcomes after 363 procedures. Am Heart J 2001;142:314-23.
704. Lee B, Godfrey M, Vitale E, et al. Linkage of Marfan syndrome and a phenotypically
related disorder to two different fibrillin genes. Nature 1991;352:330-4.
705. Lee PC, Rhee RY, Gordon RY, et al. Management of splenic artery aneurysms: the
significance of portal and essential hypertension. J Am Coll Surg 1999;189:483-90.
706. Lee R. Factor V Leiden: a clinical review. Am J Med Sci 2001;322:88-102.
707. Lee TY, Korn P, Heller JA, et al. The cost-effectiveness of a "quick-screen" program
for abdominal aortic aneurysms. Surgery 2002;132:399-407.
708. Lee VS, Martin DJ, Krinsky GA, et al. Gadolinium-enhanced MR
angiography: artifacts and pitfalls. AJR Am J Roentgenol 2000;175:197-205.
709. Leertouwer TC, Derkx FH, Pattynama PM, et al. Functional effects of renal artery
stent placement on treated and contralateral kidneys. Kidney Int 2002;62:574-9.
710. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial
stenosis: where do we stand? A meta-analysis. Radiology 2000;216:78-85.
711. Leertouwer TC, Pattynama PM, van den Berg-Huysmans A. Incidental renal artery
stenosis in peripheral vascular disease: a case for treatment? Kidney Int 2001;59:1480-3.
712. Leier CV, Baker PB, Kilman JW, et al. Cardiovascular abnormalities associated with adult
polycystic kidney disease. Ann Intern Med 1984;100:683-8.
713. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version
of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol
1992;45:1101-9.
714. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database
Syst Rev 2000;CD000990.
715. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events
in symptomatic and asymptomatic peripheral arterial disease in the general population.
Int J Epidemiol 1996;25:1172-81.
716. Leung DA, Hoffmann U, Pfammatter T, et al. Magnetic resonance angiography versus
duplex sonography for diagnosing renovascular disease. Hypertension 1999;33:726-31.
717. Levi N, Schroeder TV. Arteriosclerotic femoral artery aneurysms: a short review. J
Cardiovasc Surg (Torino) 1997; 38:335-8.
718. Levi N, Schroeder TV. Blood transfusion requirement in surgery for femoral artery
aneurysms. J Cardiovasc Surg (Torino) 1997; 38:661-3.
719. Levy PJ, Haskell L, Gordon RL. Percutaneous transluminal angioplasty of splanchnic
arteries: an alternative method to elective revascularisation in chronic visceral ischaemia.
Eur J Radiol 1987;7:239-42.
720. Levy PJ, Krausz MM, Manny J. Acute mesenteric ischemia: improved results—a
retrospective analysis of ninety-two patients. Surgery 1990;107:372-80.
721. Leyendecker JR, Elsass KD, Johnson SP, et al. The role of infrapopliteal MR
angiography in patients undergoing optimal contrast angiography for chronic limb-
threatening ischemia. J Vasc Interv Radiol 1998;9:545-51.
722. Liau CS, Ho FM, Chen MF, et al. Treatment of iatrogenic femoral artery
pseudoaneurysm with percutaneous thrombin injection. J Vasc Surg 1997;26:18-23.
723. Libertino JA, Beckmann CF. Surgery and percutaneous angioplasty in the management
of renovascular hypertension. Urol Clin North Am 1994;21:235-43.
724. Libertino JA, Bosco PJ, Ying CY, et al. Renal revascularization to preserve and restore
renal function. J Urol 1992; 147:1485-7.
725. Lievre M, Morand S, Besse B, et al. Oral Beraprost sodium, a prostaglandin I(2)
analogue, for intermittent claudication: a double-blind, randomized, multicenter
controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group.